Mimedx Group Inc (NASDAQ: MDXG) started the day on Thursday, with a price increase of 20.39% at $6.85, before settling in for the price of $5.69 at the close. Taking a more long-term approach, MDXG posted a 52-week range of $5.47-$9.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -1.19%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -21.62%. This publicly-traded company’s shares outstanding now amounts to $146.23 million, simultaneously with a float of $114.61 million. The organization now has a market capitalization sitting at $1.01 billion. At the time of writing, stock’s 50-day Moving Average stood at $6.05, while the 200-day Moving Average is $7.01.
Mimedx Group Inc (MDXG) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Mimedx Group Inc’s current insider ownership accounts for 21.94%, in contrast to 46.22% institutional ownership. Preceding that transaction, on Mar 13 ’24, Company’s General Counsel and CAO sold 20,381 for 7.95, making the whole transaction’s value amount to 162,029. This particular insider is now the holder of 479,959 in total.
Mimedx Group Inc (MDXG) Earnings and Revenue Records
Mimedx Group Inc’s EPS decrease for this current 12-month fiscal period is -21.62% and is forecasted to reach 0.32 in the upcoming year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Let’s observe the current performance indicators for Mimedx Group Inc (MDXG). It’s Quick Ratio in the last reported quarter now stands at 3.22. The Stock has managed to achieve an average true range (ATR) of 0.27. Alongside those numbers, its PE Ratio stands at $11.66, and its Beta score is 1.96. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.95. Similarly, its price to free cash flow for trailing twelve months is now 21.20.
In the same vein, MDXG’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.59, a figure that is expected to reach 0.07 in the next quarter, and analysts are predicting that it will be 0.32 at the market close of one year from today.
Technical Analysis of Mimedx Group Inc (MDXG)
If we take a close look at the recent performances of Mimedx Group Inc (NASDAQ: MDXG), its last 5-days Average volume was 0.69 million that shows plunge from its year to date volume of 0.71 million. During the previous 9 days, stock’s Stochastic %D was recorded 49.77% While, its Average True Range was 0.32.
Raw Stochastic average of Mimedx Group Inc (MDXG) in the period of the previous 100 days is set at 56.33%, which indicates a major fall in contrast to 78.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 78.44% that was higher than 47.65% volatility it exhibited in the past 100-days period.
